nodes	percent_of_prediction	percent_of_DWPC	metapath
Bortezomib—CTSG—connective tissue—age related macular degeneration	0.0491	0.134	CbGeAlD
Bortezomib—PSMA1—connective tissue—age related macular degeneration	0.0471	0.129	CbGeAlD
Bortezomib—PSMD1—eye—age related macular degeneration	0.0411	0.112	CbGeAlD
Bortezomib—PSMD1—retina—age related macular degeneration	0.0407	0.111	CbGeAlD
Bortezomib—PSMD2—eye—age related macular degeneration	0.0364	0.0995	CbGeAlD
Bortezomib—PSMD2—retina—age related macular degeneration	0.0361	0.0986	CbGeAlD
Bortezomib—PSMB1—eye—age related macular degeneration	0.0279	0.0764	CbGeAlD
Bortezomib—PSMB2—eye—age related macular degeneration	0.0272	0.0745	CbGeAlD
Bortezomib—PSMB2—retina—age related macular degeneration	0.027	0.0738	CbGeAlD
Bortezomib—PSMB2—connective tissue—age related macular degeneration	0.0263	0.0718	CbGeAlD
Bortezomib—PTGS1—connective tissue—age related macular degeneration	0.00678	0.0185	CbGeAlD
Bortezomib—PSMD2—Signaling Pathways—RHO—age related macular degeneration	0.0011	0.00173	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CFH—age related macular degeneration	0.0011	0.00173	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.00109	0.00172	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CFB—age related macular degeneration	0.00108	0.00171	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CFB—age related macular degeneration	0.00108	0.00171	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CFB—age related macular degeneration	0.00108	0.00171	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CFB—age related macular degeneration	0.00107	0.00168	CbGpPWpGaD
Bortezomib—CYP1A1—PPARA activates gene expression—CD36—age related macular degeneration	0.00106	0.00167	CbGpPWpGaD
Bortezomib—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CD36—age related macular degeneration	0.00104	0.00163	CbGpPWpGaD
Bortezomib—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.00101	0.0016	CbGpPWpGaD
Bortezomib—PSMA1—Disease—CST3—age related macular degeneration	0.000992	0.00156	CbGpPWpGaD
Bortezomib—PSMD1—Disease—CST3—age related macular degeneration	0.000987	0.00156	CbGpPWpGaD
Bortezomib—PSMD2—Disease—CST3—age related macular degeneration	0.000982	0.00155	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000972	0.00153	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—ABCA4—age related macular degeneration	0.000968	0.00153	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—ABCA4—age related macular degeneration	0.000968	0.00153	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—ABCA4—age related macular degeneration	0.000968	0.00153	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—CD36—age related macular degeneration	0.000967	0.00152	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—CD36—age related macular degeneration	0.000962	0.00152	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—CD36—age related macular degeneration	0.000957	0.00151	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—ABCA4—age related macular degeneration	0.000954	0.0015	CbGpPWpGaD
Bortezomib—PSMA1—Adaptive Immune System—C3—age related macular degeneration	0.000916	0.00144	CbGpPWpGaD
Bortezomib—PSMD1—Adaptive Immune System—C3—age related macular degeneration	0.000911	0.00144	CbGpPWpGaD
Bortezomib—PSMD2—Adaptive Immune System—C3—age related macular degeneration	0.000907	0.00143	CbGpPWpGaD
Bortezomib—PSMA1—Disease—TGFBR1—age related macular degeneration	0.000891	0.0014	CbGpPWpGaD
Bortezomib—PSMD1—Disease—TGFBR1—age related macular degeneration	0.000886	0.0014	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000886	0.0014	CbGpPWpGaD
Bortezomib—PSMD2—Disease—TGFBR1—age related macular degeneration	0.000882	0.00139	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—SQSTM1—age related macular degeneration	0.000874	0.00138	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—SQSTM1—age related macular degeneration	0.00087	0.00137	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—SQSTM1—age related macular degeneration	0.000866	0.00137	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—NMNAT1—age related macular degeneration	0.000859	0.00135	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—RHO—age related macular degeneration	0.000842	0.00133	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—RHO—age related macular degeneration	0.000842	0.00133	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—RHO—age related macular degeneration	0.000842	0.00133	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—RHO—age related macular degeneration	0.00083	0.00131	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—LIPC—age related macular degeneration	0.000782	0.00123	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—LIPC—age related macular degeneration	0.000778	0.00123	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—LIPC—age related macular degeneration	0.000774	0.00122	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—ELOVL4—age related macular degeneration	0.000757	0.00119	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CETP—age related macular degeneration	0.000754	0.00119	CbGpPWpGaD
Bortezomib—PSMB1—Disease—CST3—age related macular degeneration	0.000752	0.00118	CbGpPWpGaD
Bortezomib—PSMB5—Disease—CST3—age related macular degeneration	0.000752	0.00118	CbGpPWpGaD
Bortezomib—PSMB2—Disease—CST3—age related macular degeneration	0.000752	0.00118	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CETP—age related macular degeneration	0.000751	0.00118	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—ELOVL4—age related macular degeneration	0.000751	0.00118	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CETP—age related macular degeneration	0.000747	0.00118	CbGpPWpGaD
Bortezomib—PSMB8—Disease—CST3—age related macular degeneration	0.000741	0.00117	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—CD36—age related macular degeneration	0.000732	0.00115	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—CD36—age related macular degeneration	0.000732	0.00115	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—CD36—age related macular degeneration	0.000732	0.00115	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—CD36—age related macular degeneration	0.000722	0.00114	CbGpPWpGaD
Bortezomib—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CD36—age related macular degeneration	0.000713	0.00112	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000695	0.0011	CbGpPWpGaD
Bortezomib—PSMB5—Adaptive Immune System—C3—age related macular degeneration	0.000694	0.00109	CbGpPWpGaD
Bortezomib—PSMB2—Adaptive Immune System—C3—age related macular degeneration	0.000694	0.00109	CbGpPWpGaD
Bortezomib—PSMB1—Adaptive Immune System—C3—age related macular degeneration	0.000694	0.00109	CbGpPWpGaD
Bortezomib—PSMB8—Adaptive Immune System—C3—age related macular degeneration	0.000684	0.00108	CbGpPWpGaD
Bortezomib—PSMB2—Disease—TGFBR1—age related macular degeneration	0.000675	0.00106	CbGpPWpGaD
Bortezomib—PSMB1—Disease—TGFBR1—age related macular degeneration	0.000675	0.00106	CbGpPWpGaD
Bortezomib—PSMB5—Disease—TGFBR1—age related macular degeneration	0.000675	0.00106	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000671	0.00106	CbGpPWpGaD
Bortezomib—PSMB8—Disease—TGFBR1—age related macular degeneration	0.000665	0.00105	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—SQSTM1—age related macular degeneration	0.000663	0.00104	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—SQSTM1—age related macular degeneration	0.000663	0.00104	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—SQSTM1—age related macular degeneration	0.000663	0.00104	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—SQSTM1—age related macular degeneration	0.000653	0.00103	CbGpPWpGaD
Bortezomib—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—age related macular degeneration	0.000645	0.00102	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000624	0.000983	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000621	0.000978	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000618	0.000974	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—NMNAT1—age related macular degeneration	0.000605	0.000954	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—SLC16A8—age related macular degeneration	0.000605	0.000954	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—LIPC—age related macular degeneration	0.000592	0.000934	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—LIPC—age related macular degeneration	0.000592	0.000934	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—LIPC—age related macular degeneration	0.000592	0.000934	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CD36—age related macular degeneration	0.000586	0.000924	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—LIPC—age related macular degeneration	0.000584	0.000921	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CD36—age related macular degeneration	0.000583	0.00092	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CD36—age related macular degeneration	0.000581	0.000915	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CETP—age related macular degeneration	0.000572	0.000901	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CETP—age related macular degeneration	0.000572	0.000901	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CETP—age related macular degeneration	0.000572	0.000901	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000565	0.000891	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CETP—age related macular degeneration	0.000564	0.000888	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000563	0.000887	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—SQSTM1—age related macular degeneration	0.00056	0.000883	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—C3—age related macular degeneration	0.000556	0.000876	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—NMNAT1—age related macular degeneration	0.000555	0.000875	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—C3—age related macular degeneration	0.000553	0.000872	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—C3—age related macular degeneration	0.00055	0.000867	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—ELOVL4—age related macular degeneration	0.000529	0.000834	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—CRP—age related macular degeneration	0.000528	0.000833	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—CRP—age related macular degeneration	0.000526	0.000829	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—CRP—age related macular degeneration	0.000523	0.000825	CbGpPWpGaD
Bortezomib—PSMA1—Immune System—TLR4—age related macular degeneration	0.000507	0.000799	CbGpPWpGaD
Bortezomib—PSMD1—Immune System—TLR4—age related macular degeneration	0.000504	0.000795	CbGpPWpGaD
Bortezomib—PSMD2—Immune System—TLR4—age related macular degeneration	0.000502	0.000791	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—NMNAT1—age related macular degeneration	0.000495	0.000781	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.00049	0.000773	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—ELOVL4—age related macular degeneration	0.000485	0.000764	CbGpPWpGaD
Bortezomib—PSMA1—Disease—APOE—age related macular degeneration	0.000477	0.000753	CbGpPWpGaD
Bortezomib—PSMD1—Disease—APOE—age related macular degeneration	0.000475	0.000749	CbGpPWpGaD
Bortezomib—PSMD2—Disease—APOE—age related macular degeneration	0.000473	0.000746	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000473	0.000745	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—TGFBR1—age related macular degeneration	0.000473	0.000745	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—TGFBR1—age related macular degeneration	0.000473	0.000745	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—TGFBR1—age related macular degeneration	0.000473	0.000745	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—TGFBR1—age related macular degeneration	0.000466	0.000735	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—NMNAT1—age related macular degeneration	0.000455	0.000718	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—CD36—age related macular degeneration	0.000453	0.000715	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—NMNAT1—age related macular degeneration	0.000451	0.000712	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—CD36—age related macular degeneration	0.000451	0.000711	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000449	0.000708	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—CD36—age related macular degeneration	0.000449	0.000708	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CD36—age related macular degeneration	0.000444	0.0007	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CD36—age related macular degeneration	0.000444	0.0007	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CD36—age related macular degeneration	0.000444	0.0007	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CD36—age related macular degeneration	0.000438	0.000691	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000433	0.000683	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—ELOVL4—age related macular degeneration	0.000433	0.000682	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—SQSTM1—age related macular degeneration	0.000428	0.000675	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—SQSTM1—age related macular degeneration	0.000428	0.000675	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—SQSTM1—age related macular degeneration	0.000428	0.000675	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—SLC16A8—age related macular degeneration	0.000426	0.000672	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—SQSTM1—age related macular degeneration	0.000422	0.000666	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—C3—age related macular degeneration	0.000421	0.000664	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—C3—age related macular degeneration	0.000421	0.000664	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—C3—age related macular degeneration	0.000421	0.000664	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—C3—age related macular degeneration	0.000415	0.000654	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000403	0.000636	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000401	0.000632	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—CRP—age related macular degeneration	0.000401	0.000631	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—CRP—age related macular degeneration	0.000401	0.000631	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—CRP—age related macular degeneration	0.000401	0.000631	CbGpPWpGaD
Bortezomib—PSMA1—Metabolism—APOE—age related macular degeneration	0.0004	0.00063	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—ELOVL4—age related macular degeneration	0.000398	0.000628	CbGpPWpGaD
Bortezomib—PSMD1—Metabolism—APOE—age related macular degeneration	0.000398	0.000627	CbGpPWpGaD
Bortezomib—PSMD2—Metabolism—APOE—age related macular degeneration	0.000396	0.000624	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—CRP—age related macular degeneration	0.000395	0.000623	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—ELOVL4—age related macular degeneration	0.000395	0.000622	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—SLC16A8—age related macular degeneration	0.000391	0.000616	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000387	0.00061	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—NMNAT1—age related macular degeneration	0.000386	0.000608	CbGpPWpGaD
Bortezomib—PSMB1—Immune System—TLR4—age related macular degeneration	0.000384	0.000605	CbGpPWpGaD
Bortezomib—PSMB5—Immune System—TLR4—age related macular degeneration	0.000384	0.000605	CbGpPWpGaD
Bortezomib—PSMB2—Immune System—TLR4—age related macular degeneration	0.000384	0.000605	CbGpPWpGaD
Bortezomib—PSMB8—Immune System—TLR4—age related macular degeneration	0.000379	0.000597	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000366	0.000576	CbGpPWpGaD
Bortezomib—PSMB2—Disease—APOE—age related macular degeneration	0.000362	0.00057	CbGpPWpGaD
Bortezomib—PSMB5—Disease—APOE—age related macular degeneration	0.000362	0.00057	CbGpPWpGaD
Bortezomib—PSMB1—Disease—APOE—age related macular degeneration	0.000362	0.00057	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—C3—age related macular degeneration	0.000359	0.000566	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—C3—age related macular degeneration	0.000357	0.000564	CbGpPWpGaD
Bortezomib—PSMB8—Disease—APOE—age related macular degeneration	0.000357	0.000562	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—C3—age related macular degeneration	0.000356	0.000561	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000356	0.000561	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000353	0.000556	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—SLC16A8—age related macular degeneration	0.000349	0.00055	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—CD36—age related macular degeneration	0.000344	0.000542	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—CD36—age related macular degeneration	0.000344	0.000542	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—CD36—age related macular degeneration	0.000344	0.000542	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—CD36—age related macular degeneration	0.000339	0.000534	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—ELOVL4—age related macular degeneration	0.000337	0.000532	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—APOE—age related macular degeneration	0.000334	0.000527	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—APOE—age related macular degeneration	0.000333	0.000525	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—APOE—age related macular degeneration	0.000331	0.000522	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—KDR—age related macular degeneration	0.000328	0.000516	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—KDR—age related macular degeneration	0.000326	0.000514	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—KDR—age related macular degeneration	0.000324	0.000512	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—SLC16A8—age related macular degeneration	0.000321	0.000506	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—SLC16A8—age related macular degeneration	0.000318	0.000501	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—LIPC—age related macular degeneration	0.000312	0.000493	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—LIPC—age related macular degeneration	0.00031	0.000488	CbGpPWpGaD
Bortezomib—PSMB1—Metabolism—APOE—age related macular degeneration	0.000303	0.000478	CbGpPWpGaD
Bortezomib—PSMB5—Metabolism—APOE—age related macular degeneration	0.000303	0.000478	CbGpPWpGaD
Bortezomib—PSMB2—Metabolism—APOE—age related macular degeneration	0.000303	0.000478	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CETP—age related macular degeneration	0.000301	0.000475	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CETP—age related macular degeneration	0.000299	0.000471	CbGpPWpGaD
Bortezomib—PSMB8—Metabolism—APOE—age related macular degeneration	0.000299	0.000471	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—NMNAT1—age related macular degeneration	0.000298	0.000469	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000284	0.000448	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—CCL2—age related macular degeneration	0.000281	0.000443	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—CCL2—age related macular degeneration	0.00028	0.000441	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—CCL2—age related macular degeneration	0.000278	0.000439	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—C3—age related macular degeneration	0.000272	0.000429	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—C3—age related macular degeneration	0.000272	0.000429	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—C3—age related macular degeneration	0.000272	0.000429	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—SLC16A8—age related macular degeneration	0.000272	0.000429	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—C3—age related macular degeneration	0.000268	0.000423	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.00026	0.000411	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—ELOVL4—age related macular degeneration	0.00026	0.00041	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—APOE—age related macular degeneration	0.000253	0.000399	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—APOE—age related macular degeneration	0.000253	0.000399	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—APOE—age related macular degeneration	0.000253	0.000399	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000251	0.000395	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—APOE—age related macular degeneration	0.00025	0.000394	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—KDR—age related macular degeneration	0.000248	0.000391	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—KDR—age related macular degeneration	0.000248	0.000391	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—KDR—age related macular degeneration	0.000248	0.000391	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—KDR—age related macular degeneration	0.000245	0.000386	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000232	0.000367	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00023	0.000362	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—LIPC—age related macular degeneration	0.000218	0.000344	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—CCL2—age related macular degeneration	0.000213	0.000336	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—CCL2—age related macular degeneration	0.000213	0.000336	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—CCL2—age related macular degeneration	0.000213	0.000336	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000212	0.000334	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CETP—age related macular degeneration	0.000211	0.000332	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—CCL2—age related macular degeneration	0.00021	0.000331	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—SLC16A8—age related macular degeneration	0.00021	0.000331	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000205	0.000323	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—LIPC—age related macular degeneration	0.0002	0.000315	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CETP—age related macular degeneration	0.000193	0.000304	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.000187	0.000295	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—CD36—age related macular degeneration	0.000181	0.000286	CbGpPWpGaD
Bortezomib—PSMA1—Signaling Pathways—VEGFA—age related macular degeneration	0.00018	0.000285	CbGpPWpGaD
Bortezomib—PSMD1—Signaling Pathways—VEGFA—age related macular degeneration	0.00018	0.000283	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—CD36—age related macular degeneration	0.00018	0.000283	CbGpPWpGaD
Bortezomib—PSMD2—Signaling Pathways—VEGFA—age related macular degeneration	0.000179	0.000282	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—LIPC—age related macular degeneration	0.000179	0.000282	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CETP—age related macular degeneration	0.000172	0.000272	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—LIPC—age related macular degeneration	0.000164	0.000259	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—LIPC—age related macular degeneration	0.000163	0.000257	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism of lipids and lipoproteins—APOE—age related macular degeneration	0.00016	0.000252	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CETP—age related macular degeneration	0.000158	0.00025	CbGpPWpGaD
Bortezomib—PTGS1—Metabolism—APOE—age related macular degeneration	0.000158	0.00025	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CETP—age related macular degeneration	0.000157	0.000248	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—LIPC—age related macular degeneration	0.000139	0.000219	CbGpPWpGaD
Bortezomib—PSMB5—Signaling Pathways—VEGFA—age related macular degeneration	0.000137	0.000216	CbGpPWpGaD
Bortezomib—PSMB1—Signaling Pathways—VEGFA—age related macular degeneration	0.000137	0.000216	CbGpPWpGaD
Bortezomib—PSMB2—Signaling Pathways—VEGFA—age related macular degeneration	0.000137	0.000216	CbGpPWpGaD
Bortezomib—PSMB8—Signaling Pathways—VEGFA—age related macular degeneration	0.000135	0.000213	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CETP—age related macular degeneration	0.000134	0.000212	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—CD36—age related macular degeneration	0.000127	0.000199	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—CD36—age related macular degeneration	0.000116	0.000183	CbGpPWpGaD
Bortezomib—CYP1A1—Metabolism—APOE—age related macular degeneration	0.000112	0.000176	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—LIPC—age related macular degeneration	0.000107	0.000169	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CETP—age related macular degeneration	0.000104	0.000163	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—CD36—age related macular degeneration	0.000104	0.000163	CbGpPWpGaD
Bortezomib—CYP2C8—Metabolism—APOE—age related macular degeneration	0.000102	0.000161	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—CD36—age related macular degeneration	9.52e-05	0.00015	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—CD36—age related macular degeneration	9.44e-05	0.000149	CbGpPWpGaD
Bortezomib—CYP2C19—Metabolism—APOE—age related macular degeneration	9.13e-05	0.000144	CbGpPWpGaD
Bortezomib—CYP2D6—Metabolism—APOE—age related macular degeneration	8.4e-05	0.000132	CbGpPWpGaD
Bortezomib—CYP2C9—Metabolism—APOE—age related macular degeneration	8.33e-05	0.000131	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—CD36—age related macular degeneration	8.07e-05	0.000127	CbGpPWpGaD
Bortezomib—CYP1A2—Metabolism—APOE—age related macular degeneration	7.12e-05	0.000112	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—CD36—age related macular degeneration	6.23e-05	9.82e-05	CbGpPWpGaD
Bortezomib—CYP3A4—Metabolism—APOE—age related macular degeneration	5.49e-05	8.66e-05	CbGpPWpGaD
